Traditional apps with protected HCP functionality. Phone models receive one-year unlimited mobile phone data and service plan register on the web-based individual patient portal and receive study treatment phone software based on study assignment.
Welldoc Extends Its Digital Therapeutics Footprint Into Asian Markets
Welldoc Software Private Limiteds Annual General Meeting AGM was last held on 30 September 2019 and as per records from Ministry of Corporate Affairs MCA its balance sheet was last filed on 31 March 2019.
Welldoc business model. Curation platform over public apps. Our direct customer is the healthcare enterprise. Welldoc has a post-money valuation in the range of 100M to 500M as of Mar 1 2016 according to PrivCo.
The primary outcome is mean change in A1c over a 12-month intervention period. Our business model is best characterized as a Business to Business to Consumer B2B2C model. The Companys groundbreaking technology helps guide individuals through the complicated journey of living with chronic diseases with a goal of helping them self-manage their conditions while connecting them to their own healthcare team.
The -- no surprises here -- business model. Provider of chronic disease management services intended to help transform lives. Among other things Bergstrom was responsible for implementing the companys business model.
Prescribed apps with limited access. To aid mHealth solution providers in their efforts to develop innovative business models we have synthesized these challenges into three main categories. Given WellDocs future plans for heart disease management apps and its medication adherence component to DiabetesManager -- there may well be room for partnerships with either of those device companies.
Provides health care software solutions. We have taken an aggressive and innovative approach that utilizes sophisticated logic precise algorithms and artificial intelligence AI which integrates the most advanced mobile technology and. Welldoc is a leading digital therapeutic company revolutionizing chronic disease management to help transform lives.
Directors of Welldoc Software Private Limited are Hari Ramakrishna Kesani Billy Graham. Johnson Johnson Innovation and Hudson River Capital Partners are the most recent investors. We are the first digital health company based on a life science business model with a foundation that is built on randomized clinical trials that demonstrate significant clinical outcomes.
Welldocs platform combines a holistic approach with an evidence-based care model tailored to specific chronic conditions including diabetes hypertension behavioral health. There are 2 companies in the Welldoc Inc. WellDoc created digital health solutions long before smart phones were invented.
Of course ATT may have many other mHealth devices in their stable that have yet to be disclosed. Welldoc is transforming chronic care management with an award winning digital health platform for health plans health systems and employers to manage patients with chronic conditions. Welldoc is funded by 11 investors.
The Company develops web and mobile platforms for chronic disease management which harness the power of artificial. We are the first digital health company to conduct randomized clinical trial. Has 20 total employees across all of its locations and generates 536 million in sales USD.
Prescribed apps with limited access. The Companys groundbreaking technology helps guide individuals through the complicated journey of living with chronic diseases with a goal of helping them self-manage their conditions while connecting them to their own healthcare team. What is Welldocs business model and reimbursement strategy.
Welldoc is a leading digital therapeutic company revolutionizing chronic disease management to help transform lives. Sign up for a free trial to view exact valuation and search companies with similar valuations. There are three business models that we have seen so far and these models have different strengths and weaknesses.
Is located in Columbia MD United States and is part of the Physicians Industry. Control group patients receive usual care from their PCP. Welldocs platform combines a holistic approach with an evidence-based care model tailored to specific chronic conditions including diabetes hypertension behavioral health and more Lilly plans to submit to the FDA this year for the data-transfer module and Welldoc plans to submit to the FDA this year for the new app.
As a member of WellDocs founding team Bergstrom was instrumental in building the company and its prescribable and reimbursable digital interventions for diabetes management. Developing an effective mHealth business model will require a structured approach in order to overcome significant barriers to commercialization. The companys services offer patients and their healthcare providers with real-time and actionable information as well as diabetes educational tools that are actionable and personal enabling patients to improve their health and wellness with ease.
